申联生物
(688098)
| 流通市值：39.71亿 | | | 总市值：39.71亿 |
| 流通股本：4.11亿 | | | 总股本：4.11亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 237,694,760.86 | 121,725,138.28 | 78,741,129.63 | 303,414,652.03 |
| 营业收入 | 237,694,760.86 | 121,725,138.28 | 78,741,129.63 | 303,414,652.03 |
| 二、营业总成本 | 235,297,261.25 | 138,536,976.11 | 80,804,394.1 | 329,503,695.54 |
| 营业成本 | 96,280,433.54 | 50,158,462.42 | 32,384,277.78 | 120,611,552.52 |
| 税金及附加 | 3,454,642.14 | 2,180,461.07 | 1,135,772.06 | 4,364,696.61 |
| 销售费用 | 62,518,067.78 | 38,625,005.46 | 22,085,481.84 | 100,672,153.29 |
| 管理费用 | 41,836,977.97 | 27,418,489.4 | 14,136,293.86 | 55,234,455.58 |
| 研发费用 | 31,220,699.23 | 20,213,006.63 | 11,111,043.54 | 49,355,062.69 |
| 财务费用 | -13,559.41 | -58,448.87 | -48,474.98 | -734,225.15 |
| 其中:利息费用 | 203,354.66 | 136,378.66 | 68,249.99 | 17,062.5 |
| 其中:利息收入 | 262,231.57 | 227,198.91 | 131,664.05 | 810,938.91 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 1,697,916.05 | 2,157,584.14 | 939,856.26 | 883,276.87 |
| 加:投资收益 | -1,165,933.07 | 42,443.37 | 395,061.42 | 1,785,944.86 |
| 资产处置收益 | 269,871.6 | -46,839.3 | - | 35,769.23 |
| 资产减值损失(新) | 11,580.1 | 12,977.32 | -13,753.64 | -28,177,425.29 |
| 信用减值损失(新) | -9,595,240.4 | -4,530,675.3 | -4,234,970.81 | -8,471,632.6 |
| 其他收益 | 3,773,232.91 | 2,795,434.63 | 850,483.61 | 3,522,429.88 |
| 四、营业利润 | -2,611,073.2 | -16,380,912.97 | -4,126,587.63 | -56,510,680.56 |
| 加:营业外收入 | 1,265,674.6 | 119,601 | 0 | 23,304.32 |
| 减:营业外支出 | 3,221.41 | 3,221.41 | 3,221.41 | 306,945.28 |
| 五、利润总额 | -1,348,620.01 | -16,264,533.38 | -4,129,809.04 | -56,794,321.52 |
| 减:所得税费用 | 1,674,251.99 | -1,222,141.6 | -75,203.57 | -8,045,757.13 |
| 六、净利润 | -3,022,872 | -15,042,391.78 | -4,054,605.47 | -48,748,564.39 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | -3,022,872 | -15,042,391.78 | -4,054,605.47 | -48,748,564.39 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 278,051.56 | -12,869,700.94 | -3,019,866.61 | -44,740,058.21 |
| 少数股东损益 | -3,300,923.56 | -2,172,690.84 | -1,034,738.86 | -4,008,506.18 |
| 扣除非经常损益后的净利润 | -5,100,650.29 | -16,796,202.06 | -4,450,133.9 | -48,376,509.32 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0 | -0.03 | -0.01 | -0.11 |
| (二)稀释每股收益 | 0 | -0.03 | -0.01 | -0.11 |
| 九、综合收益总额 | -3,022,872 | -15,042,391.78 | -4,054,605.47 | -48,748,564.39 |
| 归属于母公司股东的综合收益总额 | 278,051.56 | -12,869,700.94 | -3,019,866.61 | -44,740,058.21 |
| 归属于少数股东的综合收益总额 | -3,300,923.56 | -2,172,690.84 | -1,034,738.86 | -4,008,506.18 |
| 公告日期 | 2025-10-27 | 2025-08-30 | 2025-04-30 | 2025-04-30 |
| 审计意见(境内) | | | | 标准无保留意见 |